Lenograstim and filgrastim effects on neutrophil motility in patients undergoing chemotherapy: evaluation by computer-assisted image analysis.
A
A
Azzarà
G
G
Carulli
A
A
Rizzuti-Gullaci
E
E
Capochiani
M
M
Petrini
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D001761:Bleomycin / Q000008:administration & dosage; D018821:CD18 Antigens / Q000096:biosynthesis; D002465:Cell Movement / Q000187:drug effects; D002634:Chemotaxis, Leukocyte / Q000187:drug effects*; D003520:Cyclophosphamide / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D000069585:Filgrastim; D006031:Glycosylation; D016179:Granulocyte Colony-Stimulating Factor / Q000737:chemistry / Q000494:pharmacology*; D006801:Humans; D007091:Image Processing, Computer-Assisted; D000078224:Lenograstim; D008228:Lymphoma, Non-Hodgkin / Q000097:blood* / Q000188:drug therapy; D008727:Methotrexate / Q000008:administration & dosage; D009504:Neutrophils / Q000187:drug effects* / Q000648:ultrastructure; D011241:Prednisone / Q000008:administration & dosage; D011499:Protein Processing, Post-Translational; D011994:Recombinant Proteins / Q000737:chemistry / Q000494:pharmacology*; D014750:Vincristine / Q000008:administration & dosage
D018821:CD18 Antigens; D011994:Recombinant Proteins; D003561:Cytarabine; D001761:Bleomycin; D016179:Granulocyte Colony-Stimulating Factor; D014750:Vincristine; D005047:Etoposide; D000078224:Lenograstim; D004317:Doxorubicin; D003520:Cyclophosphamide; D000069585:Filgrastim; D011241:Prednisone; D008727:Methotrexate